Top Markets
Coin of the day
Spectral Medical Inc. Spectral Medical Inc.

Spectral Medical Inc.

EDT
Classement en actions #16671
Spectral Medical Inc. focuses on the development and commercialization of... Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Prix de l'action
$0.95411796
Dernière synchronisation: 2026-09-01
Capitalisation boursière
$279.96M
Changement (1 jour)
-0.76%
Changement (1 an)
-16.23%
Pays
CA
Échange Spectral Medical Inc. (EDT)

Catégorie

Bénéfices pour Spectral Medical Inc. (EDT)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Spectral Medical Inc., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Spectral Medical Inc. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US